Zinc oxide nanoparticles and spironolactone-enhanced Nrf2/HO-1 pathway and inhibited Wnt/β-catenin pathway in adenine-induced nephrotoxicity in rats

References

• Elshehabi ME, Barakat NM, Zahran F, et al. Therapeutic role of stem cells pretreated with hyaluronic acid against chronic kidney disease in rat model. Front Sci Res Technol. 2021;3:43–50.
   Google Scholar
• Irazabal MV, Torres VE. Reactive oxygen species and redox signaling in chronic kidney disease. Cells. 2020;9(6):1342; doi:10.3390/cells9061342. Cited: in:: PMID: 32481548.
   PubMed Web of Science ®Google Scholar
• Malik SA, Modarage K, Goggolidou P. The role of WNT signalling in chronic kidney disease (CKD). Genes. 2020;11:1–19. doi:10.3390/genes11050496. Cited: in:: PMID: 32365994.
   Web of Science ®Google Scholar
• Prasad AS, Bao B. Molecular mechanisms of zinc as a Pro-antioxidant mediator: clinical therapeutic implications. Antioxidants. 2019;8(6):164; doi:10.3390/antiox8060164. Cited: in:: PMID: 31174269.
   Web of Science ®Google Scholar
• Barakat LAA, Barakat N, Zakaria MM, et al. Protective role of zinc oxide nanoparticles in kidney injury induced by cisplatin in rats. Life Sci. 2020;262:118503.
   PubMed Web of Science ®Google Scholar
• Abd El-Khalik SR, Nasif E, Arakeep HM, et al. The prospective ameliorative role of zinc oxide nanoparticles in STZ induced diabetic nephropathy in rats: mechanistic targeting of autophagy and regulating Nrf2/TXNIP/NLRP3 inflammasome signaling. Biol Trace Elem Res. 2021;200:1677–1687. doi:10.1007/s12011-021-02773-4
   PubMed Web of Science ®Google Scholar
• Capelli I, Gasperoni L, Ruggeri M, et al. New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure. J. Nephrol. 2020;33(1): 37–48.
   PubMed Web of Science ®Google Scholar
• Elseweidy MM, Shawky ME, Elswefy MS SE. Nephrotoxicity induced by cisplatin intake in experimental rats and therapeutic approach of using mesenchymal stem cells and spironolactone appl biochem biotechnol. Appl Biochem Biotechnol. 2018;184:1390–1403.
   PubMed Web of Science ®Google Scholar
• Bashandy SAE, Alaamer A, Moussa SAA, et al. Role of zinc oxide nanoparticles in alleviating hepatic fibrosis and nephrotoxicity induced by thioacetamide in rats. 2017; p. 1–36.
   Google Scholar
• Hosoya K, Minakuchi H, Wakino S, et al. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Kidney Int. 2015;87(4):749–760. doi:10.1038/ki.2014.348. Cited: in:: PMID: 25337775.
   PubMed Web of Science ®Google Scholar
• Diwan V, Brown L, Gobe GC. Adenine-induced chronic kidney disease in rats. Nephrology. 2018;23:5–11. doi:10.1111/nep.13180.
   Google Scholar
• Koga H, Hagiwara S, Ph D, et al. New a -lipoic acid derivative, DHL-HisZn, ameliorates renal ischemia-reperfusion injury in rats. J Surg Res. 2012;174(2):352–358. doi:10.1016/j.jss.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Awadalla A, Hussein AM, El-Far YM, et al. Effect of zinc oxide nanoparticles and ferulic acid on renal ischemia/reperfusion injury: possible underlying mechanisms. Biomed Pharmacother. 2021;140:111686, doi:10.1016/j.biopha.2021.111686.
   PubMed Web of Science ®Google Scholar
• Rao X, Huang X, Zhou Z, et al. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013;3:71–85.
   PubMedGoogle Scholar
• Cox B, Emili A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc. 2006;1(4):1872–1878. doi:10.1038/nprot.2006.273. Cited: in:: PMID: 17487171.
   PubMed Web of Science ®Google Scholar
• Sun H, Chen G, Wen B, et al. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling. J Pharmacol Sci. 2018;136(3):133–141. doi:10.1016/j.jphs.2018.01.003.
   PubMed Web of Science ®Google Scholar
• Shi M, McMillan KL, Wu J, et al. Cisplatin nephrotoxicity as a model of chronic kidney disease. Lab Investig. 2018;98(8):1105–1121. doi:10.1038/s41374-018-0063-2.
   PubMed Web of Science ®Google Scholar
• Medicine M. Basement membrane collagen type IV expression by human mesenchymal stem cells during adipogenic differentiation Basement membrane collagen type IV expression by human mesenchymal stem cells during adipogenic differentiation. 2016; doi:10.1111/j.1582-4934.2011.01442.x.
   Google Scholar
• Rapa SF, Di Iorio BR, Campiglia P, et al. Inflammation and oxidative stress in chronic kidney disease—potential therapeutic role of minerals,: vitamins and plant-derived metabolites. Int J Mol Sci. 2020;21(1):263; doi:10.3390/ijms21010263. Cited: in:: PMID: 31906008.
   Web of Science ®Google Scholar
• Leftheris K, Zheng Y, Lala DS. Chapter 6 - recent advances in mineralocorticoid receptor antagonists. Annu Rep Med Chem. 2011;46:89-102. doi:10.1016/B978-0-12-386009-5.00021-7.
   Google Scholar
• Ali BH, Al M, Adham SA, et al. Biomedicine & pharmacotherapy The effect of sildena fi l on rats with adenine — induced chronic kidney disease. Biomed Pharmacother. 2018;108:391–402. doi:10.1016/j.biopha.2018.09.061.
   PubMedGoogle Scholar
• Pessôa BS, Peixoto EBMI, Papadimitriou A, et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin-Angiotensin-Aldosterone Syst. 2011;13:56–66. doi:10.1177/1470320311422581.
   PubMed Web of Science ®Google Scholar
• Rodríguez-sánchez E, Navarro-garcía JA, Aceves-ripoll J, et al. Association between renal dysfunction and metalloproteinase (MMP) -9 activity in hypertensive patients. Nefrología (English Edition). 2019;39(2):184–191.
   PubMed Web of Science ®Google Scholar
• Thakur R, Sharma A, Lingaraju MC, et al. Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats. Biomed Pharmacother. 2018;101:972–980. doi:10.1016/j.biopha.2018.02.143. Cited: in:: PMID: 29635907.
   PubMed Web of Science ®Google Scholar
• Oh YJ, Kim H, Kim AJ, et al. Reduction of secreted frizzled-related protein 5 drives vascular calcification through Wnt3amediated Rho/ROCK/JNK signaling in chronic kidney disease. Int J Mol Sci. 2020;21:3539.
   Web of Science ®Google Scholar
• Boivin FJ, Sarin S, Evans JC, et al. The good and bad of β-catenin in kidney development and renal dysplasia. Front Cell Dev Biol. 2015;3:1–10. doi:10.3389/fcell.2015.00081.
   PubMed Web of Science ®Google Scholar
• Syngle A, Verma I. SAT0008 spironolactone abrogates production of proinflammatory cytokines in rheumatoid arthritis VIA inactivation of nuclear factor- kappa B. Ann Rheum Dis. 2015;74(Suppl 2):652LP – 65652. doi:10.1136/annrheumdis-2015-eular.5344.
   Google Scholar
• Zhu J, Chen Y, Yang M, et al. Aldosterone is involved in the pathogenesis of obesity-related glomerulopathy through activation of Wnt/β-catenin signaling in podocytes. Mol Med Rep. 2018;17:4589–4598. doi:10.3892/mmr.2018.8386.
   PubMed Web of Science ®Google Scholar
• Rodrı R, Uribe N, Gamba G, et al. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int. 2012;83(1):93–103. doi:10.1038/ki.2012.352.
   PubMed Web of Science ®Google Scholar
• Rombouts K, Wielant A, Hellemans K, et al. Influence of aldosterone on collagen synthesis and proliferation of rat cardiac fibroblasts. Br J Pharmacol. 2001;134(1):224–232. doi:10.1038/sj.bjp.0704247.
   PubMed Web of Science ®Google Scholar
• Feria I, Pichardo I, Juárez P, et al. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney Int. 2003;63(1):43–52. doi:10.1046/j.1523-1755.2003.00707.x. Cited: in:: PMID: 12472767.
   PubMed Web of Science ®Google Scholar
• Li MJ, Huang CX, Okello E, et al. Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology. Can J Cardiol. 2009;25(9):523–526. doi:10.1016/s0828-282x(09)70138-2. Cited: in:: PMID: 19746242.
   PubMed Web of Science ®Google Scholar
• Yuan X, Wang X, Li Y, et al. Aldosterone promotes renal interstitial fibrosis via the AIF–1/AKT/mTOR signaling pathway. Mol Med Rep. 2019;20:4033–4044. doi:10.3892/mmr.2019.10680.
   PubMed Web of Science ®Google Scholar
• Yim HE, Kim JH, Yoo KH, et al. Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney. Pediatr Res. 2011;69(5 Part 1):378–383. doi:10.1203/PDR.0b013e3182114c38. Cited: in:: PMID: 21263376.
   PubMed Web of Science ®Google Scholar
• Gulbahce-Mutlu E, Baltaci SB, Menevse E, et al. The effect of zinc and melatonin administration on lipid peroxidation, IL-6 levels, and element metabolism in DMBA-induced breast cancer in rats. Biol Trace Elem Res. 2021;199(3):1044–1051. doi:10.1007/s12011-020-02238-0.
   PubMed Web of Science ®Google Scholar
• Alomari G, Al-Trad B, Hamdan S, et al. Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats. IET Nanobiotechnol. 2021;15(5):473–483. doi:10.1049/nbt2.12026.
   PubMed Web of Science ®Google Scholar
• Guo DD, Li QN, Li CM, et al. Zinc oxide nanoparticles inhibit murine photoreceptor-derived cell proliferation and migration via reducing TGF-β and MMP-9 expression in vitro. Cell Prolif. 2015;48(2):198–208. doi:10.1111/cpr.12163. Cited: in:: PMID: 25615023.
   PubMed Web of Science ®Google Scholar
• Sehsah R, Wu W, Ichihara S, et al. Role of Nrf2 in inflammatory response in lung of mice exposed to zinc oxide nanoparticles. Part Fibre Toxicol. 2019;16:47, doi:10.1186/s12989-019-0328-y. Cited: in:: PMID: 31842927.
   PubMed Web of Science ®Google Scholar
• Thomas S, Gunasangkaran G, Arumugam VA, et al. Synthesis and characterization of zinc oxide nanoparticles of solanum nigrum and Its anticancer activity via the induction of apoptosis in cervical cancer. Biol Trace Elem Res. 2021;200:2684–2697.
   PubMed Web of Science ®Google Scholar